|
PRMT3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.741000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.784800E-01 |
| Normal-vs-Stage2 |
3.986600E-01 |
| Normal-vs-Stage3 |
6.242400E-01 |
| Normal-vs-Stage4 |
7.973600E-01 |
| Stage1-vs-Stage2 |
2.295800E-01 |
| Stage1-vs-Stage3 |
9.964000E-01 |
| Stage1-vs-Stage4 |
8.125000E-01 |
| Stage2-vs-Stage3 |
2.604800E-01 |
| Stage2-vs-Stage4 |
3.364400E-01 |
| Stage3-vs-Stage4 |
8.642800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.604200E-01 |
| Normal-vs-AfricanAmerican |
6.943000E-01 |
| Normal-vs-Asian |
1.884990E-01 |
| Caucasian-vs-AfricanAmerican |
4.445000E-01 |
| Caucasian-vs-Asian |
6.624400E-02 |
| AfricanAmerican-vs-Asian |
2.542400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.661600E-01 |
| Normal-vs-Female |
9.769600E-01 |
| Male-vs-Female |
5.871400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.770400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.664800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.746600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.809200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.462000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.354200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.655600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.855800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.868200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.768200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.541200E-01 |
| Normal-vs-Grade 2 |
8.487600E-01 |
| Normal-vs-Grade 3 |
3.190000E-01 |
| Normal-vs-Grade 4 |
8.431400E-01 |
| Grade 1-vs-Grade 2 |
8.031200E-01 |
| Grade 1-vs-Grade 3 |
5.564200E-01 |
| Grade 1-vs-Grade 4 |
9.347400E-01 |
| Grade 2-vs-Grade 3 |
4.432000E-01 |
| Grade 2-vs-Grade 4 |
7.428000E-01 |
| Grade 3-vs-Grade 4 |
4.026400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.964200E-01 |
| Normal-vs-ccB subtype |
7.252800E-01 |
| ccA subtype-vs-ccB subtype |
6.367800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.951600E-01 |
| Normal-vs-N1 |
8.782600E-01 |
| N0-vs-N1 |
8.967800E-01 |
|
|
